Literature DB >> 9822926

Sclerosing epithelioid fibrosarcoma: a study of five cases emphasizing diagnostic criteria.

B P Eyden1, C Manson, S S Banerjee, I S Roberts, M Harris.   

Abstract

AIMS: To study the clinical and histopathological features of sclerosing epithelioid fibrosarcoma, and to define diagnostic criteria for this uncommon soft-tissue tumour. METHODS AND
RESULTS: Standard histological, immunohistochemical and ultrastructural techniques were applied to five tumours from head and neck, chest wall and groin. Tumours consisted of groups of monomorphic rounded/epithelioid cells surrounded by a prominent collagenous stroma. Tumour cells showed positive vimentin staining but were negative for other markers. They contained prominent rough endoplasmic reticulum and a large Golgi apparatus which in one case was producing collagen secretion granules, an ultrastructural marker for collagen production. Three patients had medium to long-term survival (3-7 years). Of these, one was disease-free for 3 years, and two experienced multiple recurrences: one of the latter died of metastatic disease.
CONCLUSION: Criteria for diagnosing this uncommon tumour include: small to medium cell size, clear or pale cytoplasm, cellular arrangement in cords and strands, dense collagenous stroma; vimentin staining; rough endoplasmic reticulum and a Golgi apparatus producing, in well preserved examples, collagen secretion granules. The paper emphasizes the value of electron microscopy, supporting an appropriate histological picture and immunophenotype, in identifying these relatively low-grade sarcomas.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9822926     DOI: 10.1046/j.1365-2559.1998.00530.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  16 in total

1.  Unusual malignant perineurioma of soft tissue.

Authors:  M Fukunaga
Journal:  Virchows Arch       Date:  2001-08       Impact factor: 4.064

2.  Sclerosing epithelioid fibrosarcoma.

Authors:  James W Patterson; Georgi Tchernev; Anastasiya Atanasova Chokoeva; Mark R Wick
Journal:  Wien Med Wochenschr       Date:  2016-09-15

3.  Sclerosing epithelioid fibrosarcoma of the oral cavity.

Authors:  Camille T Elkins; Paul E Wakely
Journal:  Head Neck Pathol       Date:  2011-06-21

Review 4.  ¹⁸F-fluorodeoxyglucose PET/CT features and correlations with histopathologic characteristics in sclerosing epithelioid fibrosarcoma.

Authors:  Yaping Luo; Wendi Hu; Huanwen Wu; Huadan Xue; Li Huo; Fang Li; Yupei Zhao; Menghua Dai
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

5.  Oral and maxillofacial sclerosing epithelioid fibrosarcoma: report of five cases.

Authors:  Gretchen S Folk; Stephen B Williams; Robert B Foss; Julie C Fanburg-Smith
Journal:  Head Neck Pathol       Date:  2007-10-26

6.  Sclerosing epithelioid fibrosarcoma - a report of two cases with cytogenetic analysis of FUS gene rearrangement by FISH technique.

Authors:  Bharat Rekhi; Andrew L Folpe; Mahesh Deshmukh; Nirmala Ajit Jambhekar
Journal:  Pathol Oncol Res       Date:  2010-05-25       Impact factor: 3.201

7.  Epithelioid fibrosarcoma of the ovary.

Authors:  Kazuo Watanabe; Toshimitsu Suzuki
Journal:  Virchows Arch       Date:  2004-08-19       Impact factor: 4.064

Review 8.  Sclerosing epithelioid fibrosarcoma: case presentation and a systematic review.

Authors:  Christian Ossendorf; Gabriela M Studer; Beata Bode; Bruno Fuchs
Journal:  Clin Orthop Relat Res       Date:  2008-03-14       Impact factor: 4.176

9.  Sclerosing epithelioid fibrosarcoma of the bone: a case report of high resistance to chemotherapy and a survey of the literature.

Authors:  Thomas G P Grunewald; Irene von Luettichau; Gregor Weirich; Angela Wawer; Uta Behrends; Peter M Prodinger; Gernot Jundt; Stefan S Bielack; Reiner Gradinger; Stefan Burdach
Journal:  Sarcoma       Date:  2010-04-12

10.  Sclerosing epithelioid fibrosarcoma of the pituitary.

Authors:  Anamaria Massier; Bernd W Scheithauer; Harris C Taylor; Christopher Clark; Luis Llerena
Journal:  Endocr Pathol       Date:  2007       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.